Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron.
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
Iron deficiency, independent of anemia, appears to increase morbidity and mortality as well
as impairing health-related quality of life in chronic heart failure (CHF), and these effects
are compounded when patients also experience chronic kidney disease (CKD). This study was
designed to determine the effects of intravenous iron treatment on morbidity and mortality
following an initial 6-month period and a longer period of up to 5 years.